Analysis of Temozolomide

Significance of the Topic

Temozolomide is a key alkylating agent used in oncology, notably for glioblastoma treatment. Reliable quantification and impurity profiling are essential for ensuring drug efficacy, patient safety, and regulatory compliance in pharmaceutical quality control.

Objectives and Study Overview

This study presents a robust reversed-phase liquid chromatography method for the separation and quantification of temozolomide and a related compound. The primary goals are to achieve clear peak resolution, reproducible retention times, and suitable sensitivity for routine QC assays.

Methodology and Instrumentation

• Chromatographic system: Shimadzu i-Series LC-2050
• Column: Shim-pack VP-ODS (150 mm × 4.6 mm I.D., 5 µm; P/N 228-34937-91)
• Mobile phase: Water with 0.5% acetic acid containing sodium 1-hexanesulfonate (0.94 g per liter), mixed with methanol (4% v/v)
• Flow rate: 1.2 mL/min (adjusted to give ~9.5 min retention for temozolomide)
• Column temperature: 25 °C
• Injection volume: 10 µL
• Detection: UV absorbance at 270 nm

Key Results and Discussion

The chromatogram demonstrates baseline separation between the temozolomide peak (retention ~9.5 min) and the related compound. Peak shapes are sharp, and system suitability parameters (e.g., resolution, tailing factor) meet typical acceptance criteria for pharmaceutical analysis. Method repeatability shows consistent retention times and peak areas over multiple injections.

Benefits and Practical Applications

• High resolution enables accurate impurity detection and quantification.
• Robust method suitable for routine quality control laboratories.
• Simple mobile phase composition facilitates preparation and reduces costs.
• UV detection offers broad accessibility without specialized detectors.

Future Trends and Potential Applications

Advances may include coupling with mass spectrometry for enhanced specificity, use of shorter or sub-2 µm columns to reduce analysis time, and adoption of greener solvents to minimize environmental impact. Automated sample preparation and data processing can further streamline high-throughput testing.

Conclusion

The described reversed-phase LC method using the Shim-pack VP-ODS column provides a reliable, reproducible, and cost-effective approach for the determination of temozolomide and related impurities. It addresses the critical needs of pharmaceutical QC and supports regulatory compliance.

Instrumentation Used

Shimadzu i-Series LC-2050 system with Shim-pack VP-ODS column.

References

• Application News 01-00120 (JP), Shimadzu Corporation, First Edition Dec. 2021.